Airway Therapeutics continues to work “around the clock” to advance its protein replacement therapy as a potential treatment for the novel coronavirus – including a new collaboration to boost supply, while also taking the first steps toward clinical trials with the Food & Drug Administration.
Ohio Startup Bolstering Supply For Potential COVID-19 Clinical Trial
